Antimetastatic agents. I. Role of cellular procoagulants in the pathogenesis of fibrin deposition in cancer and the use of anticoagulants and/or antiplatelet drugs in cancer treatment
- PMID: 3281267
- DOI: 10.1055/s-2007-1002760
Antimetastatic agents. I. Role of cellular procoagulants in the pathogenesis of fibrin deposition in cancer and the use of anticoagulants and/or antiplatelet drugs in cancer treatment
Similar articles
-
Assessment of anti-metastatic effects of anticoagulant and antiplatelet agents using animal models of experimental lung metastasis.Methods Mol Biol. 2010;663:241-59. doi: 10.1007/978-1-60761-803-4_10. Methods Mol Biol. 2010. PMID: 20617422
-
[Cancer, hemostasis and coaguloactive drugs].Vopr Onkol. 1989;35(12):1411-8. Vopr Onkol. 1989. PMID: 2692281 Review. Russian. No abstract available.
-
Antimetastatic agents. II. Summary of the interactions of tumor cells with blood coagulation factors, platelets, fibrinolytic factors, and inflammatory cells and their soluble mediators: potential for therapeutic interventions.Semin Thromb Hemost. 1988 Jan;14(1):126-32. doi: 10.1055/s-2007-1002765. Semin Thromb Hemost. 1988. PMID: 3353730
-
Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.Crit Care Med. 2003 Apr;31(4 Suppl):S213-20. doi: 10.1097/01.CCM.0000057846.21303.AB. Crit Care Med. 2003. PMID: 12682443 Review.
-
Inhibition of platelet function: does it offer a chance of better cancer progression control?Semin Thromb Hemost. 2007 Oct;33(7):712-21. doi: 10.1055/s-2007-991540. Semin Thromb Hemost. 2007. PMID: 18000800 Review.
Cited by
-
Factor IXi-antithrombin (IXiAT) and thrombin-antithrombin (TAT) complexes in lung cancer patients.Ann Hematol. 1992 Jan;64(1):35-9. doi: 10.1007/BF01811469. Ann Hematol. 1992. PMID: 1310878
-
Hemostatic alterations in cancer patients.Cancer Metastasis Rev. 1992 Nov;11(3-4):237-48. doi: 10.1007/BF01307180. Cancer Metastasis Rev. 1992. PMID: 1423816 Review.
-
The role of fibrin in tumor metastasis.Cancer Metastasis Rev. 1992 Nov;11(3-4):283-90. doi: 10.1007/BF01307183. Cancer Metastasis Rev. 1992. PMID: 1423819 Review.
-
Hyperfibrinogenemia is associated with inflammatory mediators and poor prognosis in patients with gastric cancer.Surg Today. 2016 Dec;46(12):1394-1401. doi: 10.1007/s00595-016-1339-z. Epub 2016 May 9. Surg Today. 2016. PMID: 27160890
-
Non-tissue factor procoagulants in cancer cells.Cancer Metastasis Rev. 1992 Nov;11(3-4):267-82. doi: 10.1007/BF01307182. Cancer Metastasis Rev. 1992. PMID: 1423818 Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical